Skip to content

BMC Psychiatry

ISSN 1471-244X

67 papers in the library · 1,176 citations · publishing 2005-2026

Papers

Sort Most recent Most cited

A randomized controlled trial on the comparative effectiveness of mindfulness-based cognitive therapy and health qigong-based cognitive therapy among Chinese people with depression and anxiety disorders

BMC Psychiatry December 1, 2020 S. Chan, Wendy W. K. Chan, J. Chao et al.

Background The goal of this study was to investigate treatment outcome and related intervention processes of mindfulness-based cognitive therapy versus health qigong-based cognitive therapy versus waitlist control among individuals with mood disorders. Methods A total of 187 individuals with mood disorders were randomized and allocated into mindfulness-based cognitive therapy, health...

The introduction of mindfulness groups to a psychiatric rehabilitation in-patient setting: a feasibility study.

BMC Psychiatry June 20, 2020 Audrey Millar, Liesbeth Tip, Ruth Lennon et al. 6 citations

BACKGROUND: Patients within psychiatric rehabilitation services have multiple, complex and enduring difficulties, and are frequently described as 'treatment resistant'. This group have diagnoses of major mental health conditions, most commonly schizophrenia, often alongside a history of complex trauma, co-morbid alcohol/ substance misuse, and cognitive impairment. There is no known effective...

A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol

BMC Psychiatry June 2, 2020 J. Phillips, N. Jaworska, Elizabeth Kamler et al. 22 citations

Background Recent evidence underscores the utility of rapid-acting antidepressant interventions, such as ketamine, in alleviating symptoms of major depressive episodes (MDE). However, to date, there have been limited head-to-head comparisons of intravenous (IV) ketamine infusions with other antidepressant treatment strategies in large randomized trials. This study protocol describes an ongoing...

Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review

BMC Psychiatry January 16, 2020 Jerome Sarris, Justin Sinclair, Diana Karamacoska et al. 247 citations

BACKGROUND: Medicinal cannabis has received increased research attention over recent years due to loosening global regulatory changes. Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. Yet its potential application in the field of psychiatry is lesser known. METHODS:...

Study protocol for a randomized control trial to investigate the effectiveness of an 8-week mindfulness-integrated cognitive behavior therapy (MiCBT) transdiagnostic group intervention for primary care patients.

BMC Psychiatry January 6, 2020 Sarah Frances, Frances Shawyer, Bruno Cayoun et al.

Effective transdiagnostic treatments for patients presenting with principal or comorbid symptoms of anxiety and depression enable more efficient provision of mental health care and may be particularly suitable for the varied population seen in primary healthcare settings. Mindfulness-integrated cognitive behavior therapy (MiCBT) is a transdiagnostic intervention that integrates aspects of CBT,...

Differential executive functioning in the topology of Spirit possession or dissociative disorders: an explorative cultural study.

BMC Psychiatry December 2, 2019 Samir Al-Adawi, Yahya Al-Kalbani, Sathiya Murthi Panchatcharam et al. 14 citations

In Oman, anecdotal and impressionistic observation have helped parse and categorize various manifestations of spirit possession into two broad and distinct categories: intermittent dissociative phenomenon and transitory dissociative phenomenon. The primary aim of the present study was to compare the performance of participants on neuropsychological tests among different grades of possession....

Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial.

BMC Psychiatry November 29, 2019 Sanne Y Smith-Apeldoorn, Jolien K E Veraart, Jeanine Kamphuis et al.

There is an urgent need to develop additional treatment strategies for patients with treatment-resistant depression (TRD). The rapid but short-lived antidepressant effects of intravenous (IV) ketamine as a racemic mixture have been shown repeatedly in this population, but there is still a paucity of data on the efficacy and safety of (a) different routes of administration, and (b) ketamine's...

Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer

BMC Psychiatry October 28, 2019 Rafael G. Dos Santos, José Carlos Bouso, Jaime E. C. Hallak 17 citations

In a recent issue of the BMC Psychiatry, the evidence of effectiveness of treatments for psychiatric conditions in end-stage cancer patients was reviewed (Johnson, 2018). The review was comprehensive, and included traditional and non-traditional/alternative treatments, including herbal medicines and spirituality. However, evidence showing that classic or serotonergic hallucinogens/psychedelics...

The effect of a brief mindfulness-based intervention on personal recovery in people with bipolar disorder: a randomized controlled trial (study protocol)

BMC Psychiatry August 22, 2019 Sunny Ho‐Wan Chan, Samson Tse, Ka Fai Chung et al. 8 citations

BACKGROUND: With the advent of the recovery movement in mental health, a humanistic paradigm shift has occurred, placing the focus on personal recovery (i.e., hope, identity, and life meaning) instead of functional or clinical recovery only (i.e., symptom reduction or increases in physical function). Along the journey of recovery, people with bipolar disorder (BD) struggle to cope with...

Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature

BMC Psychiatry July 31, 2018 Timothy I. Michaels, Jennifer Purdon, Alexis Collins et al. 256 citations

As minorities are greatly underrepresented in psychedelic medicine studies, reported treatment outcomes may not generalize to all ethnic and cultural groups. Inclusion of minorities in futures studies and improved recruitment strategies are necessary to better understand the efficacy of psychedelic-assisted psychotherapy in people of color and provide all with equal opportunities for...

A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol

BMC Psychiatry November 9, 2015 Mira B. Cladder-Micus, J. Vrijsen, E. Becker et al.

BackgroundMajor depression is a common psychiatric disorder, frequently taking a chronic course. Despite provision of evidence-based treatments, including antidepressant medication and psychological treatments like cognitive behavioral therapy or interpersonal therapy, a substantial amount of patients do not recover. Mindfulness-Based Cognitive Therapy (MBCT) has been found to be effective in...

A randomized, controlled clinical trial: the effect of mindfulness-based cognitive therapy on generalized anxiety disorder among Chinese community patients: protocol for a randomized trial

BMC Psychiatry March 12, 2013 YS Wong Samuel, WS Mak Winnie, YL Cheung Eliza et al.

Abstract Background Research suggests that an eight-week Mindfulness-Based Cognitive Therapy (MBCT) program may be effective in the treatment of generalized anxiety disorders. Our objective is to compare the clinical effectiveness of the MBCT program with a psycho-education programme and usual care in reducing anxiety symptoms in people suffering from generalized anxiety disorder. Methods A...

The DARE study of relapse prevention in depression: design for a phase 1/2 translational randomised controlled trial involving mindfulness-based cognitive therapy and supported self monitoring

BMC Psychiatry March 12, 2013 Shawyer Frances, N Meadows Graham, Judd Fiona et al.

Abstract Background Depression is a common condition that typically has a relapsing course. Effective interventions targeting relapse have the potential to dramatically reduce the point prevalence of the condition. Mindfulness-based cognitive therapy (MBCT) is a group-based intervention that has shown efficacy in reducing depressive relapse. While trials of MBCT to date have met the core...

Staying well after depression: trial design and protocol

BMC Psychiatry April 30, 2010 S Duggan Danielle, J Whitaker Chris, Russell Daphne et al.

Abstract Background Depression is often a chronic relapsing condition, with relapse rates of 50-80% in those who have been depressed before. This is particularly problematic for those who become suicidal when depressed since habitual recurrence of suicidal thoughts increases likelihood of further acute suicidal episodes. Therefore the question how to prevent relapse is of particular urgency in...

An exploratory mixed methods study of the acceptability and effectiveness of mindfulness -based cognitive therapy for patients with active depression and anxiety in primary care

BMC Psychiatry April 7, 2006 Andy Finucane, Stewart W Mercer 307 citations

BACKGROUND: Mindfulness Based Cognitive Therapy (MBCT) is an 8-week course developed for patients with relapsing depression that integrates mindfulness meditation practices and cognitive theory. Previous studies have demonstrated that non-depressed participants with a history of relapsing depression are protected from relapse by participating in the course. This exploratory study examined the...

Two cases of "cannabis acute psychosis" following the administration of oral cannabis

BMC Psychiatry December 1, 2005 Bernard Favrat, Annick Ménétrey, Marc Augsburger et al.

Abstract Background Cannabis is the most commonly used illegal drug and its therapeutic aspects have a growing interest. Short-term psychotic reactions have been described but not clearly with synthetic oral THC, especially in occasional users. Case presentations We report two cases of healthy subjects who were occasional but regular cannabis users without psychiatric history who developed...